Page last updated: 2024-08-23

heme and osimertinib

heme has been researched along with osimertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, X; Cao, P; Chaib, I; Miao, J; Molina-Vila, MA; Rosell, R; Sun, R; Wang, S	1

Other Studies

1 other study(ies) available for heme and osimertinib

Article	Year
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer. Pharmacological research, 2021, Volume: 170 Topics: Acrylamides; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Heme; Heme Oxygenase-1; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Reactive Oxygen Species; Xenograft Model Antitumor Assays	2021

Article

Year

Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer.

Pharmacological research, 2021, Volume: 170

Topics: Acrylamides; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Heme; Heme Oxygenase-1; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2021